PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 29, 2026Clinical Case Reports0 citationsOpen Access

AA Amyloidosis Resulting From Unintended Discontinuation of Rheumatoid Arthritis Therapy due to Cognitive Impairment

View Full Paper
KIKenji IshiguroSKShunta Kaneko

Key Points

  • The aim is to highlight the complications arising from unintended discontinuation of rheumatoid arthritis therapy due to cognitive impairment.
  • Case report of a 78-year-old woman with advanced dementia and RA.
  • Evaluated laboratory markers, including serum AA levels and proteinuria.
  • Conducted an abdominal skin punch biopsy to confirm AA amyloid deposition.
  • Elevated inflammatory markers and serum AA levels were found in the patient.
  • Renal dysfunction persisted despite low-dose glucocorticoid treatment.
  • AA amyloid deposition was confirmed via skin biopsy, illustrating diagnostic challenges.

Abstract

ABSTRACT Amyloid A (AA) amyloidosis is a serious complication of chronic inflammatory diseases, including rheumatoid arthritis (RA). A 78‐year‐old woman with advanced dementia developed progressive renal dysfunction following prolonged, unintentional RA treatment discontinuation. Laboratory evaluation demonstrated elevated inflammatory markers, serum AA levels, and proteinuria. Because renal biopsy was not feasible, an abdominal skin punch biopsy revealed AA amyloid deposition despite the absence of skin lesions. Low‐dose glucocorticoids improved inflammatory markers; however, renal dysfunction persisted. This case highlights the risk of treatment interruption in cognitively impaired older adults and the diagnostic value of skin biopsy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ishiguro et al. (2026) studied this question.

synapsesocial.com/papers/6a192e79fab5b468c44179d7https://doi.org/10.1002/ccr3.72822
Ask AI
Helpful
Bookmark
Share
View Full Paper